Opportunity ID: 91074

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-12-023
Funding Opportunity Title: Clinical Trials Planning Studies for Rare Thrombotic and Hemostatic Disorders (U34)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 02, 2011
Last Updated Date: Oct 21, 2013
Original Closing Date for Applications: Oct 17, 2013
Current Closing Date for Applications: Nov 01, 2013
Archive Date: Dec 01, 2013
Estimated Total Program Funding: $7,200,000
Award Ceiling: $225,000
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Private institutions of higher education
State governments
Native American tribal governments (Federally recognized)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Small businesses
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Foreign (non-U.S.) components of U.S. Organizations are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA issued by the National Heart, Lung, and Blood Institute invites applications to obtain critical and necessary support in the planning and development of feasible and well designed multicenter clinical trials focused on rare hemostatic and thrombotic disorders. The Clinical Trials Development Resource for Hematologic Disorders (U24) (RFA-HL-12-016) will provide guidance to investigators on trial design, biostatistics, clinical trial management, and regulatory requirements during the funding period.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-023.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Modified Archive Date based on new Expiration Date, per NOT-OD-14-003. Oct 21, 2013
Oct 21, 2013

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-12-023
Funding Opportunity Title: Clinical Trials Planning Studies for Rare Thrombotic and Hemostatic Disorders (U34)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 02, 2011
Last Updated Date: Oct 21, 2013
Original Closing Date for Applications: Oct 17, 2013
Current Closing Date for Applications: Nov 01, 2013
Archive Date: Dec 01, 2013
Estimated Total Program Funding: $7,200,000
Award Ceiling: $225,000
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Private institutions of higher education
State governments
Native American tribal governments (Federally recognized)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Small businesses
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Foreign (non-U.S.) components of U.S. Organizations are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA issued by the National Heart, Lung, and Blood Institute invites applications to obtain critical and necessary support in the planning and development of feasible and well designed multicenter clinical trials focused on rare hemostatic and thrombotic disorders. The Clinical Trials Development Resource for Hematologic Disorders (U24) (RFA-HL-12-016) will provide guidance to investigators on trial design, biostatistics, clinical trial management, and regulatory requirements during the funding period.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-023.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HL-12-023
Funding Opportunity Title: Clinical Trials Planning Studies for Rare Thrombotic and Hemostatic Disorders (U34)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.839 — Blood Diseases and Resources Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 21, 2013
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Oct 17, 2013
Archive Date: Nov 17, 2013
Estimated Total Program Funding: $7,200,000
Award Ceiling: $225,000
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
City or township governments
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Independent school districts
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Foreign (non-U.S.) components of U.S. Organizations are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA issued by the National Heart, Lung, and Blood Institute invites applications to obtain critical and necessary support in the planning and development of feasible and well designed multicenter clinical trials focused on rare hemostatic and thrombotic disorders. The Clinical Trials Development Resource for Hematologic Disorders (U24) (RFA-HL-12-016) will provide guidance to investigators on trial design, biostatistics, clinical trial management, and regulatory requirements during the funding period.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-023.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.839 ADOBE-FORMS-B1 ADOBE-FORMS-B1 PKG00051210 Sep 13, 2011 Sep 24, 2013 View
93.839 FORMS-C Use for due dates after 9/24/2013 PKG00181452 Sep 16, 2013 Nov 01, 2013 View

Package 1

Mandatory forms

91074 RR_SF424_1_2-1.2.pdf

91074 RR_OtherProjectInfo_1_3-1.3.pdf

91074 RR_KeyPersonExpanded_1_2-1.2.pdf

91074 PerformanceSite_1_4-1.4.pdf

91074 PHS398_ResearchPlan_1_3-1.3.pdf

91074 PHS398_CoverPageSupplement_1_4-1.4.pdf

91074 PHS398_Checklist_1_3-1.3.pdf

Optional forms

91074 RR_Budget-1.1.pdf

91074 RR_SubawardBudget-1.2.pdf

91074 PHS_CoverLetter_1_2-1.2.pdf

91074 PHS398_ModularBudget-1.1.pdf

Package 2

Mandatory forms

91074 RR_SF424_2_0-2.0.pdf

91074 PHS398_ResearchPlan_2_0-2.0.pdf

91074 PHS398_CoverPageSupplement_2_0-2.0.pdf

91074 RR_KeyPersonExpanded_2_0-2.0.pdf

91074 RR_OtherProjectInfo_1_3-1.3.pdf

91074 PerformanceSite_2_0-2.0.pdf

Optional forms

91074 RR_SubawardBudget30_1_3-1.3.pdf

91074 PlannedReport-1.0.pdf

91074 PHS398_CumulativeInclusionReport-1.0.pdf

91074 PHS398_ModularBudget_1_2-1.2.pdf

91074 RR_Budget_1_3-1.3.pdf

2025-07-13T03:47:21-05:00

Share This Post, Choose Your Platform!

About the Author: